211 related articles for article (PubMed ID: 23877252)
1. Pharmacoepidemiological characterisation of zolpidem and zopiclone usage.
Victorri-Vigneau C; Feuillet F; Wainstein L; Grall-Bronnec M; Pivette J; Chaslerie A; Sébille V; Jolliet P
Eur J Clin Pharmacol; 2013 Nov; 69(11):1965-72. PubMed ID: 23877252
[TBL] [Abstract][Full Text] [Related]
2. Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users.
Yen CF; Yen CN; Ko CH; Hwang TJ; Chen CS; Chen TT; Su PW; Chen ST; Lin JJ
Subst Use Misuse; 2015 Feb; 50(3):350-7. PubMed ID: 25458710
[TBL] [Abstract][Full Text] [Related]
3. The French addictovigilance network clinical assessment: Z-drugs, true false twins.
Rousselet M; Feuillet F; Gerardin M; Jolliet P; Hardouin JB; Victorri-Vigneau C
Expert Opin Drug Saf; 2017 Sep; 16(9):1063-1069. PubMed ID: 28649864
[TBL] [Abstract][Full Text] [Related]
4. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.
Hajak G; Müller WE; Wittchen HU; Pittrow D; Kirch W
Addiction; 2003 Oct; 98(10):1371-8. PubMed ID: 14519173
[TBL] [Abstract][Full Text] [Related]
5. [High usage of zolpidem and zopiclone. Cross-sectional study using claims data].
Hoffmann F; Pfannkuche M; Glaeske G
Nervenarzt; 2008 Jan; 79(1):67-72. PubMed ID: 17457554
[TBL] [Abstract][Full Text] [Related]
6. Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany.
Hoffmann F; Hies M; Glaeske G
Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1071-7. PubMed ID: 20665597
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.
Wainstein L; Victorri-Vigneau C; Sébille V; Hardouin JB; Feuillet F; Pivette J; Chaslerie A; Jolliet P
Int Clin Psychopharmacol; 2011 Jan; 26(1):54-62. PubMed ID: 20881845
[TBL] [Abstract][Full Text] [Related]
8. [Dependency of non-benzodiazepine hypnotics. Two case reports].
Ströhle A; Antonijevic IA; Steiger A; Sonntag A
Nervenarzt; 1999 Jan; 70(1):72-5. PubMed ID: 10087521
[TBL] [Abstract][Full Text] [Related]
9. [Benzodiazepine hypnotics, zolpidem and zopiclone on private prescriptions: use between 1993 and 2012].
Hoffmann F; Glaeske G
Nervenarzt; 2014 Nov; 85(11):1402-9. PubMed ID: 24663439
[TBL] [Abstract][Full Text] [Related]
10. Long-term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugs.
Andersen AB; Frydenberg M
Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):378-85. PubMed ID: 21259378
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
Tsutsui S;
J Int Med Res; 2001; 29(3):163-77. PubMed ID: 11471853
[TBL] [Abstract][Full Text] [Related]
12. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.
Schifano F; Chiappini S; Corkery JM; Guirguis A
Int J Neuropsychopharmacol; 2019 Apr; 22(4):270-277. PubMed ID: 30722037
[TBL] [Abstract][Full Text] [Related]
13. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers.
Gustavsen I; Al-Sammurraie M; Mørland J; Bramness JG
Accid Anal Prev; 2009 May; 41(3):462-6. PubMed ID: 19393793
[TBL] [Abstract][Full Text] [Related]
14. [Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007].
Hoffmann F; Scharffetter W; Glaeske G
Nervenarzt; 2009 May; 80(5):578-83. PubMed ID: 19169658
[TBL] [Abstract][Full Text] [Related]
15. New, Occasional, and Frequent Use of Zolpidem or Zopiclone (Alone and in Combination) and the Risk of Injurious Road Traffic Crashes in Older Adult Drivers: A Population-Based Case-Control and Case-Crossover Study.
Nevriana A; Möller J; Laflamme L; Monárrez-Espino J
CNS Drugs; 2017 Aug; 31(8):711-722. PubMed ID: 28669021
[TBL] [Abstract][Full Text] [Related]
16. Comparative tolerability of newer agents for insomnia.
Zammit G
Drug Saf; 2009; 32(9):735-48. PubMed ID: 19670914
[TBL] [Abstract][Full Text] [Related]
17. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors.
Hausken AM; Furu K; Skurtveit S; Engeland A; Bramness JG
Eur J Clin Pharmacol; 2009 Mar; 65(3):295-301. PubMed ID: 18810397
[TBL] [Abstract][Full Text] [Related]
18. Hypnotic dependence: zolpidem and zopiclone too.
Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
Drover DR
Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
